ArticleFrontiers in nutrition2025
Association between the life's essential 8 health behaviors score and all-cause mortality in cardiovascular-kidney-metabolic syndrome patients.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular-kidney-metabolic (CKM) syndrome, a novel and multistage disorder recently proposed by the American Heart Association (AHA), highlights the intricate connection between cardiovascular, renal, and metabolic illnesses. Poor CKM health is highly prevalent in the U.S. We aimed to examine the association of Life's Essential 8 (LE8), the AHA's key measures for improving and maintaining cardiovascular health (CVH), with all-cause mortality among U.S. CKM syndrome patients. Methods: This population-based prospective cohort study analyzed data of adults in the National Health and Nutrition Examination Survey from 2011 to 2018, with linked mortality information until 2019. LE8 score, which included four health behaviors and four health factors, was categorized into low (0-49), moderate (50-79), and high (80-100) CVH. Five CKM syndrome stages (stages 0-4) were defined according to the 2023 AHA guidelines, with advanced (stages 3 or 4) and non-advanced (stages 1 or 2) disease. Multivariable Cox regression and restricted cubic spline models were used to assess the associations. Results: Among 11,638 CKM syndrome patients (2,060 advanced stages), 831 deaths occurred over a median follow-up of 5.0 years. Interestingly, the relationship between total LE8 score and all-cause mortality was only significant in advanced CKM syndrome patients, while not significant in non-advanced CKM syndrome patients. Further analyses of LE8 subscales revealed that advanced CKM syndrome patients with moderate and high LE8 health behaviors score exhibited a reduced risk of all-cause mortality (moderate: hazard ratio, 0.52; 95% confidence interval, 0.39-0.70; high: 0.35; 0.24-0.49), as well as non-advanced CKM syndrome patients (moderate: 0.75; 0.55-0.98; high: 0.38; 0.24-0.59). Population attributable fraction suggested that 22.5 and 23.9% of all-cause mortality attributed to poor or moderate LE8 health behaviors score could be avoided if high score was achieved in advanced and non-advanced CKM syndrome patients. Conclusion: Our study revealed a significant association between the LE8 health behaviors score and all-cause mortality in both advanced and non-advanced CKM syndrome patients, underscoring the value of this score in enhancing risk management approaches for CKM syndrome patients in future research and clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.